Hyperfine (HYPR) EBT Margin Growth (3y) (2024 - 2026)
Hyperfine (HYPR) EBT Margin Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | -429.00 |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 574.00 |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 55.00 |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 764.00 |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 835.00 |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 598.00 |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 125.00 |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 631.00 |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 423.00 |
| 10 | Hyperfine | 89.93 Mn | 45.16 Mn | 1.98 Mn | 7,645.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7,645.00 |
| Mar 31, 2026 | 24,055.00 |
| Dec 31, 2025 | 80,537.00 |
| Sep 30, 2025 | 24,035.00 |
| Jun 30, 2025 | 116,852.00 |
| Mar 31, 2025 | 113,484.00 |
| Dec 31, 2024 | 553,515.00 |
| Sep 30, 2024 | 413,488.00 |
| Jun 30, 2024 | 379,292.00 |
| Mar 31, 2024 | 205,581.00 |